Market Overview

Encephalopathy | A Pipeline Analysis Report 2018 | Technavio


Technavio has announced their latest pipeline analysis report on the encephalopathy
. The report includes a detailed analysis of the pipeline
molecules under investigation within the defined data collection period
to treat encephalopathy.

This press release features multimedia. View the full release here:

Technavio has published a new report on the drug development pipeline for encephalopathy, including  ...

Technavio has published a new report on the drug development pipeline for encephalopathy, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market in the future.

This report is available at a USD 1,000 discount for a limited time
market snapshot before purchasing

Encephalopathy: Market overview

Encephalopathy is a common brain disease or malfunction of the brain. It
is a syndrome that is characterized by multiple brain disorders. It may
be caused by metabolic or mitochondrial dysfunction, infectious agents
(bacteria, virus, or prion), increased pressure in the skull, prolonged
exposure to toxins, chronic progressive trauma, or lack of oxygen or
poor nutrition of blood flow to the brain. It differs from person to
person and can be both temporary and permanent. Furthermore, bacterial
infection, liver damage, brain anoxia, and kidney failure are the common
causes of encephalopathy.

According to a senior market research analyst at Technavio, "The
disease can develop at any age and can be present at the time of birth
or may never be cured. According to a renowned research, 30% to 45% of
people with liver cirrhosis have hepatic encephalopathy. As a result,
with rising incidences of the disease, the drug development for
encephalopathy is likely to increase considerably in the forthcoming

Encephalopathy: Segmentation analysis

This pipeline analysis report segments the encephalopathy market based
on therapies employed (monotherapy and combination therapy), RoA (oral,
intravenous, parenteral, transdermal, intravenous/subcutaneous, and
intranasal), therapeutic modality (small molecule, stem cell therapy,
biological, peptide, monoclonal antibody, oligonucleotides, antibody,
microbiome and hormone), targets (serotonin receptor, GABA A receptor,
ammonia, KCNQ potassium channel, JCV, CDKL5, stem cells, and others),
MoA (serotonin receptor modulator, GABA A receptor modulator, ammonia
scavengers, KCNQ potassium channel agonist, JCV inhibition, CDKL5
inhibitor, cell replacements, and others), geographical segmentation
(US, Europe, Australia, New Zealand, Canada, and Hong Kong) and
recruitment status (active, not recruiting, completed, not yet
recruiting, and recruiting). It provides an in-depth analysis of the
prominent factors influencing the market, including drivers,
opportunities, trends, and industry-specific challenges.

Based on therapeutic modality, more than 73% of the molecules that are
being investigated for the treatment of encephalopathy are small

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team

View Comments and Join the Discussion!